Related Experiment Videos
Leukotriene transformation by guinea-pig lungs
Prostaglandins, Leukotrienes, and Medicine
|February 1, 1983
Summary
Guinea-pig lung homogenates metabolize leukotrienes, inactivating LTD4 and LTE4 while initially activating LTA4 and LTC4. These findings confirm enzymes for leukotriene formation and inactivation in lungs.
Area of Science:
- Biochemistry
- Pharmacology
- Respiratory Physiology
Background:
- Leukotrienes (LTs) are inflammatory mediators implicated in asthma and allergic reactions.
- Understanding leukotriene metabolism is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the metabolic fate of synthetic leukotrienes (LTA4, LTB4, LTC4, LTD4, LTE4) in guinea-pig lung homogenates.
- To identify enzymes involved in leukotriene inactivation and transformation within lung tissue.
Main Methods:
- Incubation of synthetic leukotrienes with guinea-pig lung homogenates at 37°C for up to 180 minutes.
- Assay of remaining biological activity using cascade superfusion systems with guinea-pig ileum and lung parenchymal strips.
- Evaluation of the effects of lipoxygenase inhibitors and gamma-glutamyl-O-carboxy-phenylhydrazide.
Main Results:
- Leukotriene D4 (LTD4) exhibited a half-life of approximately 50 minutes, with inactivation plateauing around 120 minutes.
- Leukotriene A4 (LTA4) and Leukotriene C4 (LTC4) showed initial increases in biological activity, suggesting conversion to more potent forms like LTD4.
- Leukotriene B4 (LTB4) and Leukotriene E4 (LTE4) were not significantly inactivated by the lung homogenates.
- Lipoxygenase inhibitors did not affect LTD4 inactivation or LTA4 transformation, indicating non-lipoxygenase pathways are involved.
Conclusions:
- Guinea-pig lung homogenates possess enzymes capable of both forming and inactivating various leukotrienes.
- LTD4 undergoes inactivation, while LTA4 and LTC4 can be transformed into more potent mediators.
- LTB4 and LTE4 appear resistant to inactivation in this model.